1,4-Naphthalenedione,2-bromo-
1,4-Naphthalenedione,2-bromo- structure
|
Common Name | 1,4-Naphthalenedione,2-bromo- | ||
|---|---|---|---|---|
| CAS Number | 2065-37-4 | Molecular Weight | 237.04900 | |
| Density | 1.757g/cm3 | Boiling Point | 324.2ºC at 760mmHg | |
| Molecular Formula | C10H5BrO2 | Melting Point | 131-133ºC(lit.) | |
| MSDS | Chinese USA | Flash Point | 124.7ºC | |
| Symbol |
GHS07 |
Signal Word | Warning | |
| Name | 2-bromonaphthalene-1,4-dione |
|---|---|
| Synonym | More Synonyms |
| Density | 1.757g/cm3 |
|---|---|
| Boiling Point | 324.2ºC at 760mmHg |
| Melting Point | 131-133ºC(lit.) |
| Molecular Formula | C10H5BrO2 |
| Molecular Weight | 237.04900 |
| Flash Point | 124.7ºC |
| Exact Mass | 235.94700 |
| PSA | 34.14000 |
| LogP | 2.34440 |
| Vapour Pressure | 0.00025mmHg at 25°C |
| Index of Refraction | 1.674 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
| Hazard Codes | Xi: Irritant; |
| Risk Phrases | 36/37/38 |
| Safety Phrases | 26-36 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2914700090 |
| HS Code | 2914700090 |
|---|---|
| Summary | HS: 2914700090 halogenated, sulphonated, nitrated or nitrosated derivatives of ketones and quinones, whether or not with other oxygen function Tax rebate rate:9.0% Supervision conditions:none VAT:17.0% MFN tariff:5.5% General tariff:30.0% |
|
Potent naphthoquinones against antimony-sensitive and -resistant Leishmania parasites: synthesis of novel α- and nor-α-lapachone-based 1,2,3-triazoles by copper-catalyzed azide-alkyne cycloaddition.
Eur. J. Med. Chem. 63 , 523-30, (2013) Continuing our screening program for novel anti-parasite compounds, we synthesized seven 1,4-naphthoquinones coupled to 1,2,3-triazoles, five nor-β-lapachone-based 1,2,3-triazoles and ten α-lapachone-... |
|
|
2-Bromo-1,4-naphthoquinone: a potentially improved substitute of menadione in Apatone™ therapy.
Braz. J. Med. Biol. Res. 45(8) , 701-10, (2012) Apatone™, a combination of menadione (2-methyl-1,4-naphthoquinone, VK3) and ascorbic acid (vitamin C, VC) is a new strategy for cancer treatment. Part of its effect on tumor cells is related to the ce... |
|
|
Expedient, one-pot preparation of fused indoles via CAN-catalyzed three-component domino sequences and their transformation into polyheterocyclic compounds containing pyrrolo[1,2-a]azepine fragments.
Org. Biomol. Chem. 8(15) , 3426-36, (2010) The CAN-catalyzed three-component between reaction between primary amines, beta-dicarbonyl compounds and naphthoquinones or 2-bromonaphthoquinones afforded, respectively, 5-hydroxybenzo[g]indoles and ... |
| MFCD00629301 |
| 2-bromo-1,4-naphtoquinone |
| 2-bromonaphthoquinone |
| 3-Bromo-1,4-naphthoquinone |
| 2-bromo-naphthalene-1,4-dione |
| 2-Bromo-1,4-naphthoquinone |